RELATED UPDATES:
 New Revelations in Ukraine Lead to Tightening Global Sanctions (April 8, 2022)
 Western Companies Starting to Feel Impact of Russian Sanctions (March 24, 2022)
FinCEN Encourages “Increased Vigilance” and Highlights Red Flags for Evasion of Russian Sanctions including Use of Virtual Currency (March 16, 2022)
DOJ Launches “Task Force KleptoCapture” in Response to Russian Invasion (March 9, 2022)
U.S. and Allies Significantly Expand Sanctions and Related Restrictions on Russia and Belarus (Feb. 28, 2022)
Additional Sanctions on Russia and the Importance of Business Contingency Planning (Feb. 23, 2022)
Biden Administration Issues Initial Ukraine Sanctions (Feb. 22, 2022)

As the crisis on the Ukrainian border persists, companies with exposure to Russian markets and counterparties are being forced to reckon with the possibility that a Russian invasion of Ukraine could result in imposition of the most serious economic and trade sanctions ever imposed on Russia.  Such sanctions are being openly discussed and debated politically, and are the clearly preferred first response to any aggressive military moves Russia might make to cross the Ukrainian border in locations where Russian military assets have been staged over the last several weeks.  While obviously preferable to a global military conflict, efforts to sanction Russia to a level sufficient to reverse an incursion into Ukraine will have significant ripple effects throughout numerous industries and with numerous significant multinational organizations.

Great Point Partners (GPP) has acquired Performance Cell Manufacturing (PCM), according to a news release.

PCM, based in San Diego and founded in 2002, is a contract development and manufacturing organization of cell therapy products for biopharmaceutical companies.

As part of the transaction, PCM is changing its name to Cellipont Bioservices.

GPP,…

Lee Equity Partners has announced it has invested in Therapy Partner Solutions (TPS).

TPS, based in Fernandina Beach, Fla., delivers physical therapy services across three divisions: clinic partnership, management services and performance solutions. Founded in 2017, TPS states that its family of companies has offices in nine states and services clients in nearly all…

As COVID-19 continues to spread, recent news has highlighted the risk of “take-home” COVID-19 cases and the potential for “never-ending” liability for businesses. So-called take-home lawsuits are filed by employees’ domestic relatives for diseases or illnesses caused by exposures that allegedly traveled home through the employee.
On Jan. 12, 2022, Reuters reported “at least 23…

One Equity Partners (OEP) has announced it has completed a strategic investment of InfuCare Rx

InfuCare Rx, based in Fairfield, N.J., is a national provider of specialty infusion therapies and comprehensive clinical therapy management services to patients with complex conditions. Founded in 2015, the company reports servicing more than 4,000 patients across 43 states.

OEP…

This past year, the U.S. Securities and Exchange Commission followed through on its commitment to aggressively enforce securities laws in digital assets markets. As a result, it sharpened its focus on cryptocurrency exchanges and lending products.

Read on for an overview and analysis of SEC activity in cryptocurrency and what to expect in 2022.

About…

Elizabeth Holmes, founder of Theranos, was convicted of three counts of wire fraud and one count of conspiracy to commit wire fraud. The verdict follows a high-profile, fifteen-week trial in federal court in San Francisco.  Holmes was alleged to have defrauded investors, medical professionals, patients, and the public by exaggerating and making false statements about the accuracy of Theranos’s blood-testing technology. The government’s prosecution demonstrates the Department of Justice’s commitment to prosecuting white collar crime, particularly in the tech and healthcare industries.

SEC v. Fusion Hotel Mgmt. LLC, et al. was filed in the Southern District of California on December 14, 2021, claiming violations of the Securities Act of 1933 (“Securities Act”) and the Securities Exchange Act of 1934 (“Exchange Act”). The complaint alleges: (1) fraud in connection with the purchase or sale of securities in violation of Section 10b of the Exchange Act and Rule 10b-5 thereunder; and (2) fraud in the offer or sale of securities in violation of Section 17(a) of the Securities Act.

The Securities and Exchange Commission (“SEC”) brought this enforcement action against Defendant Denny Bhakta (“Bhakta”) and two entities that he founded and controlled, Defendants Fusion Hotel Management, LLC and Fusion Hospitality Corporation (together “Fusion” and, collectively with Bhakta, “Defendants”).

WindRose Health Investors has announced it has completed the recapitalization of Terrapin Pharmacy.

Terrapin, based in Annapolis, Md., is a specialized pharmacy primarily serving individuals diagnosed with severe and persistent mental illnesses in the Mid-Atlantic region. Founded in 2005, the company states it serves skilled nursing and rehabilitation facilities, assisted living facilities and…